Physician profile
Parag Mehta
NPI 1831164029
$841.80
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $151 · 2021: $235 · 2022: $291.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $155.82 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $84.55 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $77.57 | 2021-2022 | |
| Lilly USA, LLC | $57.45 | 2022 | |
| Sk Life Science, INC. | $51.65 | 2020 | |
| Biogen, INC. | $44.44 | 2021 | |
| Allergan, INC. | $37.37 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $37.24 | 2021 | |
| Abbvie INC. | $32.55 | 2021-2022 | |
| Vertiflex, INC. | $32.02 | 2019 | |
| Harmony Biosciences LLC | $29.60 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $26.32 | 2020-2021 | |
| Lundbeck LLC | $24.81 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.97 | 2022 | |
| Bausch Health US, LLC | $20.53 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.24 | 2022 | |
| Neurocrine Biosciences, INC. | $17.68 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.10 | 2019 | |
| Amgen INC. | $14.34 | 2019 | |
| Kyowa Kirin, INC. | $12.86 | 2022 | |
| Zyla Life Sciences, INC. | $11.71 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parag Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.